Table 3.
Mibefradil Dose Level (mg per day) | Age and Gender | Pathology | Review Assessment by Site Investigator | Central Review |
---|---|---|---|---|
100 | 67 F | GBM | Partial response | Stable disease |
200 | 50 M | GBM | Partial response | Stable disease |
200 | 43 F | GBM | Partial response | Partial response |
300 | 33 M | GBM | Complete response | Complete response |
350 (MTD) | 71 M | GBM | Complete response | Stable disease |
350 (MTD) | 43 M | GBM | Complete response | Stable disease |
GBM = glioblastoma.